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Summary. Experimental and clinical studies have shown that HAp granules and powder may be successfully applied
in reconstruction of bone defects. Composite HAp/PLLA biomaterial embodies good characteristics of each of these
biomaterials. Differences in porosity, microstructure, compressive consistency as well as in bioresorbility of
HAp/PLLA are achieved by using PLLA of different mole masses. The aim of this study was to analyse light
microscopy of the tissue reaction and changes of implants made of combination of syngeneic bone fragments and
HAp/PLLA biocomposites with PLLA molecule mass of 430 000 (HP2) and 50 000 (HP3). The mice were divided into
4 experimental studies, 8 animals each. Two groups underwent implantation, one group of mice was falsely operated,
and one group was used for general control. Pathohistological analysis of implants was performed three months after
subcutaneous implantation.  Phagocytosis of HAp/ PLLA and bone was noticed on both implants’ preparations. Blood
vessels were also noticed, confirming the process of angiogenesis around the implants’ particles. The holes around
particles of biocomposites and bone fragments represented the signs of their resorption. The presence of multinuclear
cells between implants’ particles was observed and it was more prominent in HP3 implants. Osteogenesis is more
intense in HP3 and ectopic hematopoesis is present. Our results show that designed HAp/PLLA biocomposites have
good biocompatibility, their combination with bone fragments of a vital bone enables osteogenesis and hematopoesis
and these processes are more prominent if PLLA biocomposite with lower molecular mass was used.
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Introduction
Implantation of biomaterial is nowadays one of im-
portant trends in solving the problem of bone tissue loss.
Calcium hydroxiapatite (HAp), as the most representa-
tive bone element, has become a serious candidate for
such implantations. Experimental and clinical studies
have shown that HAp granules and powder may be suc-
cessfully applied to reconstruction of bone defects (1,2).
It has been shown that HAp has good compatibility and
bioinactivity and appropriate consistency. On the other
hand, HAp is not so used in bone discontinuity due to its
fragility, because natural bone shows elasticity and great
resistance to stretching owing to the presence of fibril-
lary protein component and collagen. Synthetic polymer
poly-L-lactide (PLLA) is often used as polymeric mate-
rial and has some features, which make it useful for
combining with HAp (3,4). Fibers of PLLA may
strengthen HAp and its good bioresorbility provides
space for tissue extension (5). Composite biomaterial
HAp/PLLA embodies good features of each of these
biomaterials (6). Differences in porosity, microstructure,
compressive consistency as well as bioresorbility of
HAp/PLLA may be achieved by using PLLA with dif-
ferent mole masses (7,8,9). The most appropriate way of
recognizing the usability of biocomposite is its implan-
tation into the organism. Subcutaneous implantation is
relatively often used in such studies, because it is simple
and microenvironment of implant enables the occur-
rence of ectopic osteogenesis (10).
The aim of the study
The aim of the study was to analyse by means of
light microscopy, the tissue reaction and the changes of
implants made of combination of bone fragments and
HAp/PLLA biocomposites of different molecule mass
(50 000 and 430 000) three months after subcutaneous
implantation.
Material and methods
Experimental animals: Syngeneic Balb/c mice
were used (male, 3 months old, and weight -24-26 g.).
The animals were fed by ad libidum and kept on con-
stant temperature of 23oC.
Implanted material: Biocomposites made of 80% of
HAp and 20% of PLLA and syngeneic bone fragments
were used. Biocomposite with molecule mass (MM)
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PLLA of 430 000 was labeled as HP2, and biocomposite
with MM PLLA of 50 000 was labeled as HP3. Before
implantation composites were crushed up in a very fine
powder in mortar, disinfected in 70% alcohol and rinsed
out in sterile physiological solution. The bone for
implantation was taken from another mouse and crashed
up in a sterile physiological solution. The same amounts
of biocomposite powder and bone fragments were mixed
with fibrin glue, which enabled formation of a lump,
1mm in diameter, which was then implanted.
Subcutaneous implantation: The lump made of
combination of bone fragments and HAp/PLLA bio-
composites was subcutaneously implanted through the
top of the wide needle 4/ 18 into intracapsular region of
the back. Before implantation, the skin of the mouse
was disinfected with alcohol and after implantation
mice were intraperitoneally given antibiotic.
Experimental design: One mouse underwent the
implantation of only one material, so that 2 experimen-
tal groups of 8 animals were made. The groups were
labeled as HP2, with PLLA 430 000, and HP3, with
PLLA 50 000. Three months after implantation, the
animals were sacrificed by cervical dislocation and after
that the extraction of the implant was performed.
Pathohistological analysis: The samples of implant
were fixed in Brasil-Bouine fixative for 3 hours and post-
fixed in 4% buffered formaline during the night. Fixed
implants were decalcinised electrolitically in water solu-
tion 8 vol% HCl and 10 vol% of formic acid. The process
of decalcination was conducted for two hours at 100 V
and 50 mA. The tissue was then dehydrated in alcohol
and implanted into paraplast. Sections of 3-6 micrometers
were stained by haematoxillin and eosin (HE). Dehy-
drated portions were fixed on glass and then analyzed on
light microscope. In particular, the connection between
implant and surrounding tissue was observed.
Results
HP2.  Phagocytosis of HAp and bones is noticed on
preparations. Blood vessels are also visible, confirming
the process of angiogenesis in surrounding particles of
implants. There are groups of cells in form of granulo-
mas in some spots. A tiny connective capsule was
formed around the implant. Figure 1 illustrates the holes
as the consequence of resorption of biocomposites and
the presence of multinuclear cells between particles in
connective tissue. Large particles of material have not
been resorbed yet, but phagocytosis and signs of re-
sorption are present on peryphery. Figure 2 shows the
presence of several multinuclear cells, the signs of re-
sorption, and bone formation.
HP3. Phagocytosis of HAp and bone fragments can
be noticed on preparations. Mature fibrous tissue of cap-
sule with few cell elements is formed around the im-
plant. Ectopic hematopoesis with megacariocytes is
very prominent in some spots. Figure 3 shows wide
spaces around grains of HAp, which is probably the
consequence of intensive resorption. Cell density is
relatively low in spite of good vascularization. Figure 4
shows ectopic hematopoesis and osteogenesis. In one
part of bone fragment the biocomposite is present sur-
rounded by an empty field, which is probably the conse-
quence of resorption. The signs of resorption are present
on bone fragment as well. A white and red line is
present in hematopoetic tissue.
Fig. 1. Resorption of implanted biomaterial HP2 (40×, HE)
Fig. 2. Resorption of  implanted bone fragments close to HP2
particules (40×, HE)
Fig. 3.  Good tissue vascularization around implanted
biomaterial HP3  (40×, HE)
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Fig. 4.  Ectopic haematopoiesis and osteogenesis in implant
close to biocomposite HP3 (40×, HE)   
Discussion
Subcutaneous implantations represent a common
model for the examination of the characteristics of bio-
material. These experiments enable the perception of
biocompatibility, bioresorbility, interaction with the
tissues in the organism, and some other biofunctional
characteristics. The possibility of this model to induce
osteogenesis is very valuable. In such a way it is possi-
ble to recognize very important factors and conditions
necessary for reparation of bone tissue (10,11). Our
model, therefore, represents a simulation of interskeletal
implantation, because the fragments of vital bone are
mixed with the examined ceramics, stick with fibrin
glue, and implanted bone fragments imitate autologous
ones due to the donor who is syngeneic animal.
Both examined materials had good bioresorbility.
Osteogenic and angiogenic activity has been found in
the presence of implanted fragments of vital bone. More
prominent resorption of multinuclear cells by phagocy-
tosis was noticed on HP2 material, while greater amount
of material was resorbed in case of HP3, which had
been already shown in earlier experiments (12). On the
other hand, ectopic osteogenesis and hematopoesis, as
well as vascularization were more prominent in im-
plants with HP3 material. Since these materials differ
only in PLLA molecule mass, the processes that depend
on molecule mass of polylactides influence the stated
differences. As it was shown in our previous study (12),
resorption was faster if molecule mass was lower. This
might be the reason that three months after implantation
such implants had less engaged phagocytic system. Ob-
viously, cell conditions with such cytokine balance pre-
serve intensive hematopoesis and certain osteogenesis.
In the study of cylindric subcutaneous implants of
poly-L-lactide, poly-L/D-lactide and poly- L/DL-lactide
Mainil et al. reported that the fall of molecule mass of
implants was the most intense one month after implan-
tation, but none of the polymers was completely re-
sorbed within a year. Inflammatory reaction around
implanted biomaterials was dependent on the form of
the implant and features of its surface, porosity and
chemical stability (13). In our experiment it was con-
firmed that tissue reaction on polylactides used in this
study was manifested by formation of the capsule
around the implant and the presence of fibroblast,
macrophages, polymorphonuclear cells and cells char-
acteristic for reaction to the foreign body. Thereby, cell
reaction to the implant was more intense around poly-
mers that undergo a faster decomposition, which was
registered. Generally, cell reaction to implant was more
intense on disconnected endings of bone fragments and
rough surfaces of implants than around flat surface.
Conclusion
The examined composite materials made of hy-
droxiapatite and polylactide show good biocompatibil-
ity. Resorbtion was more prominent on biocomposite
with lower molecule mass of polylactide. Osteogenesis,
hematopoesis and angiogenesis are performed subcuta-
neously in the presence of both examined biocompo-
sites. Three months after implantation the signs of these
processes are more visible in the presence of polylactide
particles of lower molecule mass.
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Kratak sadržaj: Eksperimentalna i klinička istraživanja su pokazala da se granule i prah HAp mogu uspešno primeniti
za rekonstrukciju koštanih defekata. Kompozitni biomaterijal HAp/PLLA objedinjuje dobre osobine koje poseduje
svaki od ovih biomaterijala. Razlike u poroznosti, mikrostrukturi, kompresionoj čvrstoći kao i bioresorbilnost
HAp/PLLA postižu se korišćenjem PLLA različitih molskih masa. Cilj rada je bio da se svetlosnom mikroskopijom
analiziraju odgovor tkiva i promene implantata napravljenih od kombinacije singenih koštanih fragmenata i
biokompozita HAp/PLLA sa PLLA molekulske mase od 430 000 (HP2) i 50 000 (HP3). Miševi su bili podeljeni u 4
eksperimentalne grupe od po 8 životinja. U dve grupe je urađena implantacija, jedna grupa miševa su bili lažno
operisani, a jedna grupa je služila kao opšta kontrola. Posle 3 meseca od subkutane implantacije rađena je
patohistološka analiza implantata. Na preparatima oba tipa implantata se vidi fagocitoza HAp/PLLA i kosti. Takođe
su vidljivi krvni sudovi koji svedoče o procesu angiogeneze u okolini partikula implantata. Prazna polja oko partikula
biokompozita i koštanih fragmenata predstavljaju znake njihove resorpcije. Vidljivo je prisustvo multinuklearnih
ćelija između partikula implantata, a to je izraženije u HP3  implantatima. U HP3 je intenzivnija osteogeneza i
prisutna je ektopična hematopoeza. Naši rezultati pokazuju da dizajnirani biokompoziti HAp/PLLA imaju dobru
biokompatibilnost, da je u njihovoj kombinaciji sa koštanim fragmentima žive kosti moguća osteogeneza i
hematopoeza i da su ovi procesi izraženiji ako je u biokompozitu PLLA manje molekulske mase.
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